Literature DB >> 9443730

Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.

K Higashi1, T Nishikawa, H Seki, M Oguchi, Y Nambu, Y Ueda, K Yuasa, H Tonami, T Okimura, I Yamamoto.   

Abstract

UNLABELLED: We compared the diagnostic value of [18F]2-fluoro-2-deoxy-D-glucose (FDG) PET imaging and 201Tl SPECT imaging in the detection of primary lung cancer and mediastinal lymph node metastases.
METHODS: Thirty-three patients with histologically-proven primary lung cancer were examined with both FDG PET and TI SPECT (early and delayed scans) within a week of each study. For semiquantitative analysis, the tumor-to-nontumor activity ratio (T-to-N ratio) was calculated.
RESULTS: Although both techniques delineated focal lesions with an increase in tracer accumulation in 28 patients, PET identified three additional patients in whom Tl SPECT images did not visualize any lesions on both early and delayed scans. In the detection of lung cancer of less than 2 cm in size, FDG PET provided higher sensitivity (six of seven, 85.7%) than did Tl SPECT early scan (one of seven, 14.3%) and delayed scan (four of seven, 57.1%). Neither technique visualized any lesions in two patients who had bronchioloalveolar carcinoma. The T-to-N ratio was significantly higher with FDG PET (10.39 +/- 6.63) than it was with Tl SPECT (early scan, 2.37 +/- 0.86; delayed scan, 3.01 +/- 1.01) (p < 0.0001), whereas there was significant positive correlation between the FDG T-to-N ratio and the thallium T-to-N ratio (p < 0.01). Twenty-two patients had thoracotomies. Regarding the staging of mediastinal nodes, FDG PET detected mediastinal lymph node metastasis that was negative on Tl SPECT, whereas both techniques excluded tumor involvement in enlarged node at CT.
CONCLUSION: Both techniques have clinical value for the noninvasive detection of primary lung cancer that is 2 cm or greater in diameter. However, if a PET camera is available, FDG PET is considered the method of choice for the evaluation of patients with suspected primary lung cancer that is less than 2 cm in diameter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443730

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

Review 1.  18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.

Authors:  G Laking; P Price
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT.

Authors:  Jing Gu; Pek-Lan Khong; Silun Wang; Queenie Chan; Wailun Law; Jingbo Zhang
Journal:  Mol Imaging Biol       Date:  2010-09-25       Impact factor: 3.488

3.  Lobar mucinous bronchioloalveolar carcinoma of the lung showing negative FDG uptake on integrated PET/CT.

Authors:  Yon Mi Sung; Kyung Soo Lee; Byung-Tae Kim; Joungho Han; Eun Jeong Lee
Journal:  Eur Radiol       Date:  2005-02-17       Impact factor: 5.315

4.  Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.

Authors:  S M Weiner; A Otte; M Schumacher; R Klein; J Gutfleisch; I Brink; P Otto; E U Nitzsche; E Moser; H H Peter
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

5.  Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404.

Authors:  Abigail E Besemer; Benjamin Titz; Joseph J Grudzinski; Jamey P Weichert; John S Kuo; H Ian Robins; Lance T Hall; Bryan P Bednarz
Journal:  Phys Med Biol       Date:  2017-07-06       Impact factor: 3.609

Review 6.  Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging.

Authors:  Jessica C Sieren; Yoshiharu Ohno; Hisanobu Koyama; Kazuro Sugimura; Geoffrey McLennan
Journal:  J Magn Reson Imaging       Date:  2010-12       Impact factor: 4.813

Review 7.  Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer.

Authors:  Henk Kramer; Harry J M Groen
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

8.  Unusual False-Positive Mesenteric Lymph Nodes Detected by PET/CT in a Metastatic Survey of Lung Cancer.

Authors:  Hirohiko Kamiyama; Kazuhiro Sakamoto; Koichiro Niwa; Shun Ishiyama; Makoto Takahashi; Yutaka Kojima; Michitoshi Goto; Yuichi Tomiki; Itsuko Nakamichi; Shiaki Oh; Kenji Suzuki
Journal:  Case Rep Gastroenterol       Date:  2016-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.